Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
Cohen, Yael C., Magen, Hila, Lavi, Noa, Gatt, Moshe E., Chubar, Evgeni, Horowitz, Nethanel, Kreiniz, Natalia, Tadmor, Tamar, Trestman, Svetlana, Vitkon, Roy, Rouvio, Ory, Shvetz, Olga, Shaulov, Adir,Language:
english
Journal:
Annals of Hematology
DOI:
10.1007/s00277-020-03985-9
Date:
March, 2020
File:
PDF, 518 KB
english, 2020